MedPath

To see the results of Itraconazole tablets in operated patients of Allergic Fungal Rhinosinositis.

Not Applicable
Conditions
Health Condition 1: J019- Acute sinusitis, unspecified
Registration Number
CTRI/2022/04/042152
Lead Sponsor
All India Institute of Medical Sciences Jodhpur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Adult patients with Allergic fungal rhino-sinusitis undergoing FESS

2. Previously operated cases of chronic allergic rhino-sinusitis undergoing Revision FESS.

Exclusion Criteria

1.Patients with a previous history of sensitivity to Itraconazole

2.Patients who have received post-operative steroids.

3.Patient on immunosuppressive drugs or diagnosis of immunodeficiency disease

4.Patients previously treated with post-operative Itraconazole.

5.Pregnancy.

6.Patients having hepatic dysfunction

7.Patients <18 years of age.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath